Lv1
48 积分 2021-05-21 加入
Structural Basis for the Dual Recognition of IL-12 and IL-23 by Ustekinumab
4天前
已完结
Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells
4天前
已完结
Reshaping Pfizer’s drug discovery priorities
6天前
已完结
Top companies and drugs by sales in 2025
7天前
已完结
An allosteric site on cereblon
7天前
已完结
Top companies and drugs by sales in 2025
10天前
已完结
An allosteric site on cereblon
10天前
已关闭
What Happens in Successful Optimizations? A Survey of 2018–2024 Literature
10天前
已完结
Understanding the therapeutic toolkit for inflammatory bowel disease
11天前
已完结
IBD disease-modifying therapies: insights from emerging therapeutics
12天前
已完结